# YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

Source: https://onco.cc/trials/nct06662669/  
OnCo record `nct06662669` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of gemcitabine and nab-paclitaxel in pancreatic cancer, run by Shanghai YingLi Pharmaceutical Co. Ltd., not yet recruiting.

## Summary

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer is a phase 1/2, randomised interventional study registered as NCT06662669 by Shanghai YingLi Pharmaceutical Co. Ltd., with a registry enrolment figure of 120 participants, started 2024-11-30 and due to reach its primary completion in 2027-09-30. Interventions recorded: YL-13027; HY-0102; Gemcitabine; Nab-paclitaxel. Conditions listed: Metastatic Pancreatic Cancer. Primary outcome: Objective response rate; Progression-free survival. Pancreatic eligibility wording from the registry: "* Subject has histologically or cytologically confirmed metastatic pancreatic ductal adenocarcinoma". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06662669
- Phase: 1/2
- Setting: A Randomized, Open, Parallel-controlled, Multi-center , Phase Ib/II Clinical Trial of YL-13027 and/or HY-0102 Combined With AG（Nab-paclitaxel and Gemcitabine) Regimen Chemotherapy for Metastatic Pancreatic Cancer
- Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
- Enrolled: 120

## Sources

- ClinicalTrials.gov NCT06662669: https://clinicaltrials.gov/study/NCT06662669

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Nab-paclitaxel](https://onco.cc/drugs/nab-paclitaxel/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06662669.json